Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients
Mar 17, 2026, 14:32

Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients

Kunal Mahajan, Director and Chief Interventional Cardiologist at Himachal Heart Institute, shared a post on X about a recent article he and his colleagues co-authored, adding:

“Happy to share our study in the Journal of Clinical Lipidology.

In ACS patients treated with triple oral lipid-lowering therapy, lipoprotein(a) increased significantly after ACS, and higher baseline lipoprotein(a) predicted failure to achieve low-density lipoprotein cholesterol less than fifty milligrams per deciliter at one month.”

Title:  Changes in Lipoprotein(a) and Their Association With LDL-C in ACS Patients Treated with Triple Oral Lipid-Lowering Therapy

Authors: Kunal Mahajan, Nitin Mahajan, Jai Bharat Sharma, Surender Himral, Tanuj Bhatia, Deep Dutta

Read the Full Article on Journal of Clinical Lipidology

 

Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients

Stay updated on all scientific advances with Hemostasis Today.